Report Detail

Medical Devices & Consumables Global Subcutaneous Drug Delivery Devices Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4604439
  • |
  • 02 August, 2024
  • |
  • Global
  • |
  • 92 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Subcutaneous Drug Delivery Devices market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
A subcutaneous drug delivery device having a housing having an internal reservoir in communication with a drug delivery needle via a fluid path. An expandable chamber disposed adjacent to the reservoir forces drug from the reservoir to the needle when supplied with a gas.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Subcutaneous Drug Delivery Devices industry chain, the market status of Hospitals (Prefilled Injectable, Filled Injectable), Clinics (Prefilled Injectable, Filled Injectable), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Subcutaneous Drug Delivery Devices.
Regionally, the report analyzes the Subcutaneous Drug Delivery Devices markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Subcutaneous Drug Delivery Devices market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Subcutaneous Drug Delivery Devices market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Subcutaneous Drug Delivery Devices industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Prefilled Injectable, Filled Injectable).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Subcutaneous Drug Delivery Devices market.
Regional Analysis: The report involves examining the Subcutaneous Drug Delivery Devices market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Subcutaneous Drug Delivery Devices market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Subcutaneous Drug Delivery Devices:
Company Analysis: Report covers individual Subcutaneous Drug Delivery Devices manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Subcutaneous Drug Delivery Devices This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Subcutaneous Drug Delivery Devices. It assesses the current state, advancements, and potential future developments in Subcutaneous Drug Delivery Devices areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Subcutaneous Drug Delivery Devices market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Subcutaneous Drug Delivery Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Prefilled Injectable
Filled Injectable
Market segment by Application
Hospitals
Clinics
Others
Major players covered
BD
Insulet Corporation
Enable Injections
West Pharmaceutical Services, Inc
Ypsomed AG
Elcam Medical
Amgen
Wilhelm Haselmeier
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Subcutaneous Drug Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Subcutaneous Drug Delivery Devices, with price, sales, revenue and global market share of Subcutaneous Drug Delivery Devices from 2019 to 2024.
Chapter 3, the Subcutaneous Drug Delivery Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Subcutaneous Drug Delivery Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Subcutaneous Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Subcutaneous Drug Delivery Devices.
Chapter 14 and 15, to describe Subcutaneous Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Subcutaneous Drug Delivery Devices
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Subcutaneous Drug Delivery Devices Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Prefilled Injectable
    • 1.3.3 Filled Injectable
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Subcutaneous Drug Delivery Devices Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Others
  • 1.5 Global Subcutaneous Drug Delivery Devices Market Size & Forecast
    • 1.5.1 Global Subcutaneous Drug Delivery Devices Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Subcutaneous Drug Delivery Devices Sales Quantity (2019-2030)
    • 1.5.3 Global Subcutaneous Drug Delivery Devices Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 BD
    • 2.1.1 BD Details
    • 2.1.2 BD Major Business
    • 2.1.3 BD Subcutaneous Drug Delivery Devices Product and Services
    • 2.1.4 BD Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 BD Recent Developments/Updates
  • 2.2 Insulet Corporation
    • 2.2.1 Insulet Corporation Details
    • 2.2.2 Insulet Corporation Major Business
    • 2.2.3 Insulet Corporation Subcutaneous Drug Delivery Devices Product and Services
    • 2.2.4 Insulet Corporation Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Insulet Corporation Recent Developments/Updates
  • 2.3 Enable Injections
    • 2.3.1 Enable Injections Details
    • 2.3.2 Enable Injections Major Business
    • 2.3.3 Enable Injections Subcutaneous Drug Delivery Devices Product and Services
    • 2.3.4 Enable Injections Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Enable Injections Recent Developments/Updates
  • 2.4 West Pharmaceutical Services, Inc
    • 2.4.1 West Pharmaceutical Services, Inc Details
    • 2.4.2 West Pharmaceutical Services, Inc Major Business
    • 2.4.3 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product and Services
    • 2.4.4 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 West Pharmaceutical Services, Inc Recent Developments/Updates
  • 2.5 Ypsomed AG
    • 2.5.1 Ypsomed AG Details
    • 2.5.2 Ypsomed AG Major Business
    • 2.5.3 Ypsomed AG Subcutaneous Drug Delivery Devices Product and Services
    • 2.5.4 Ypsomed AG Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Ypsomed AG Recent Developments/Updates
  • 2.6 Elcam Medical
    • 2.6.1 Elcam Medical Details
    • 2.6.2 Elcam Medical Major Business
    • 2.6.3 Elcam Medical Subcutaneous Drug Delivery Devices Product and Services
    • 2.6.4 Elcam Medical Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Elcam Medical Recent Developments/Updates
  • 2.7 Amgen
    • 2.7.1 Amgen Details
    • 2.7.2 Amgen Major Business
    • 2.7.3 Amgen Subcutaneous Drug Delivery Devices Product and Services
    • 2.7.4 Amgen Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Amgen Recent Developments/Updates
  • 2.8 Wilhelm Haselmeier
    • 2.8.1 Wilhelm Haselmeier Details
    • 2.8.2 Wilhelm Haselmeier Major Business
    • 2.8.3 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product and Services
    • 2.8.4 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Wilhelm Haselmeier Recent Developments/Updates

3 Competitive Environment: Subcutaneous Drug Delivery Devices by Manufacturer

  • 3.1 Global Subcutaneous Drug Delivery Devices Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Subcutaneous Drug Delivery Devices Revenue by Manufacturer (2019-2024)
  • 3.3 Global Subcutaneous Drug Delivery Devices Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Subcutaneous Drug Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Subcutaneous Drug Delivery Devices Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Subcutaneous Drug Delivery Devices Manufacturer Market Share in 2023
  • 3.5 Subcutaneous Drug Delivery Devices Market: Overall Company Footprint Analysis
    • 3.5.1 Subcutaneous Drug Delivery Devices Market: Region Footprint
    • 3.5.2 Subcutaneous Drug Delivery Devices Market: Company Product Type Footprint
    • 3.5.3 Subcutaneous Drug Delivery Devices Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Subcutaneous Drug Delivery Devices Market Size by Region
    • 4.1.1 Global Subcutaneous Drug Delivery Devices Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Subcutaneous Drug Delivery Devices Consumption Value by Region (2019-2030)
    • 4.1.3 Global Subcutaneous Drug Delivery Devices Average Price by Region (2019-2030)
  • 4.2 North America Subcutaneous Drug Delivery Devices Consumption Value (2019-2030)
  • 4.3 Europe Subcutaneous Drug Delivery Devices Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value (2019-2030)
  • 4.5 South America Subcutaneous Drug Delivery Devices Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Subcutaneous Drug Delivery Devices Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Subcutaneous Drug Delivery Devices Sales Quantity by Type (2019-2030)
  • 5.2 Global Subcutaneous Drug Delivery Devices Consumption Value by Type (2019-2030)
  • 5.3 Global Subcutaneous Drug Delivery Devices Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Subcutaneous Drug Delivery Devices Sales Quantity by Application (2019-2030)
  • 6.2 Global Subcutaneous Drug Delivery Devices Consumption Value by Application (2019-2030)
  • 6.3 Global Subcutaneous Drug Delivery Devices Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2019-2030)
  • 7.2 North America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2019-2030)
  • 7.3 North America Subcutaneous Drug Delivery Devices Market Size by Country
    • 7.3.1 North America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Subcutaneous Drug Delivery Devices Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Subcutaneous Drug Delivery Devices Sales Quantity by Type (2019-2030)
  • 8.2 Europe Subcutaneous Drug Delivery Devices Sales Quantity by Application (2019-2030)
  • 8.3 Europe Subcutaneous Drug Delivery Devices Market Size by Country
    • 8.3.1 Europe Subcutaneous Drug Delivery Devices Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Subcutaneous Drug Delivery Devices Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Subcutaneous Drug Delivery Devices Market Size by Region
    • 9.3.1 Asia-Pacific Subcutaneous Drug Delivery Devices Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Subcutaneous Drug Delivery Devices Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Subcutaneous Drug Delivery Devices Sales Quantity by Type (2019-2030)
  • 10.2 South America Subcutaneous Drug Delivery Devices Sales Quantity by Application (2019-2030)
  • 10.3 South America Subcutaneous Drug Delivery Devices Market Size by Country
    • 10.3.1 South America Subcutaneous Drug Delivery Devices Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Subcutaneous Drug Delivery Devices Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Subcutaneous Drug Delivery Devices Market Size by Country
    • 11.3.1 Middle East & Africa Subcutaneous Drug Delivery Devices Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Subcutaneous Drug Delivery Devices Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Subcutaneous Drug Delivery Devices Market Drivers
  • 12.2 Subcutaneous Drug Delivery Devices Market Restraints
  • 12.3 Subcutaneous Drug Delivery Devices Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Subcutaneous Drug Delivery Devices and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Subcutaneous Drug Delivery Devices
  • 13.3 Subcutaneous Drug Delivery Devices Production Process
  • 13.4 Subcutaneous Drug Delivery Devices Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Subcutaneous Drug Delivery Devices Typical Distributors
  • 14.3 Subcutaneous Drug Delivery Devices Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Subcutaneous Drug Delivery Devices. Industry analysis & Market Report on Subcutaneous Drug Delivery Devices is a syndicated market report, published as Global Subcutaneous Drug Delivery Devices Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Subcutaneous Drug Delivery Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report